← Back to Patent Explorer
US4774227A Expired / Lapsed US ⏱️ 0.0 years remaining

Collagen compositions for bone repair containing autogeneic marrow

Assignee: Ramot at Tel Aviv University Ltd
•
Filing: 1986-02-14
•
Granted: 1988-09-27
•
Expires: 2006-02-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A composition which combines autogenic bone marrow with a suspension of purified atelopeptide reconstituted collagen is used to repair bone defects in mammals.

Inventors

  • 👤 Karl A. Piez
  • 👤 Shlomo Weintraub

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:18
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/3604; A61L27/3608; A61F; A61F2/00; A61F2/02; A61F2/28; A61K; A61K35/00; A61K35/12; A61K35/28; A61L27/14; A61L27/22; A61L27/24; A61L27/3641; A61L27/3645; A61L27/365; Y; Y10; Y10S; Y10S128/00; Y10S128/08

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 26 words
A method to mediate the repair of bone defects which comprises placing into said defect a composition containing reconstituted fibrillar atelopeptide collagen and autogeneic bone marrow.
Claim 2
Independent Claim 26 words
A method to mediate the repair of bone defects which comprises placing into said defect a composition containing reconstituted fibrillar atelopeptide collagen and autogeneic bone marrow.
Claim 3
Dependent Claim 25 words
The method of claim 1 wherein the collagen is supplied as an aqueous suspension containing 10-100 mg/ml and is 50%-95% of said composition by volume.
Claim 4
Dependent Claim 12 words
The method of claim 1 wherein the collagen is of xenogeneic origin.
Claim 5
Dependent Claim 12 words
The method of claim 3 wherein the collagen is of bovine origin.
Claim 6
Dependent Claim 13 words
The method of claim 1 wherein the composition is injected into the defect.
Claim 7
Dependent Claim 28 words
A composition for the repair of bone defects which comprises (a) an aqueous suspensions containing 10-100 mg/ml of reconstituted fibrillar atelopeptide purified collagen, and (b) autogeneic bone marrow.
Claim 8
Dependent Claim 28 words
A composition for the repair of bone defects which comprises (a) an aqueous suspensions containing 10-100 mg/ml of reconstituted fibrillar atelopeptide purified collagen, and (b) autogeneic bone marrow.
Claim 9
Dependent Claim 16 words
The composition of claim 6 wherein the collagen suspension comprises 50%-95% by volume of the composition.
Claim 10
Dependent Claim 10 words
The composition of claim 6 which is an injectable suspension.

References Cited (Backward Citations)

US4347234A Cited
US4394370A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-09-27 1992-03-28 1992-09-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-09-27 1996-03-28 1996-09-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-09-27 2000-03-28 2000-09-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag